Trials / Conditions / Rabies Post-exposure Prophylaxis
Rabies Post-exposure Prophylaxis
5 registered clinical trials studyying Rabies Post-exposure Prophylaxis — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Real World Evidence Study of SYN023 in Children Exposed to Rabies NCT07327307 | Synermore Biologics (Suzhou) Co., Ltd. | — |
| Completed | SYN023 With Rabies Vaccine in Healthy Pediatric Subjects NCT07342257 | Synermore Biologics (Suzhou) Co., Ltd. | Phase 1 |
| Completed | Study to Evaluate GR1801's Efficacy and Safety NCT05846568 | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | Phase 3 |
| Completed | Immunogenicity Assessment of Subjects Receiving Rabies Post-exposure Prophylaxis in Cambodia NCT05684185 | Institut Pasteur du Cambodge | — |
| Completed | Purified Rabies Vaccine for Human Use (Chick-embryo Cell) NCT00345319 | Novartis Vaccines | Phase 3 |